SITC Resource Library

Targets for Cancer IO: A Deep Dive, Modulations of Tregs in clinical trials 

10-03-2023 09:34

This is the library for the Enduring Materials from the Modulations of Tregs in clinical trials that was conducted on September 22, 2023.

Moderators:
  • Sergio Quezada, PhD - University College of London
  • Aurelien Marabelle, MD, PhD - Gustave Roussy
    Faculties:
    • Vaios Karanikas, PhD - Roche Innovation Center Zurich
    • Peter Luo, PhD – Adagene Inc.
    • Shimon Sakaguchi, MD, PhD – Kyoto University
    • Pan Zheng, MD, PhD – OncoC4, Inc.

     

    Acknowledgements

    Targets for Cancer IO: A Deep Dive Series 3 is supported, in part, by grants from Genentech, a member of the Roche Group, and Kite.GenentechKite

    Interested in Supporting this program?

    Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.

    Statistics
    0 Favorited
    92 Views
    5 Files
    0 Shares
    64 Downloads
    Attachment(s)
    pdf file
    Unleashing Efficacy of a Masked, Anti-CTLA-4 SAFEbody wi...   2.35 MB   1 version
    Uploaded - 10-03-2023
    Meeting: 2023 Deep Dive in Cancer Immunotherapy Targets: Modulation of Tregs in Clinical Trials Presenter: Dr. Peter Luo, PhD; Date: September 22, 2023
    pdf file
    Preserving CTLA-4 Checkpoint Function for Safer and More...   5.50 MB   1 version
    Uploaded - 10-03-2023
    Meeting: 2023 Deep Dive in Cancer Immunotherapy Targets: Modulation of Tregs in Clinical Trials Presenter: Dr. Pan Zheng, MD, PhD; Date: September 22, 2023
    pptx file
    Treg, immune checkpoint blockade, and beyond   69.26 MB   1 version
    Uploaded - 10-03-2023
    Meeting: 2023 Deep Dive in Cancer Immunotherapy Targets: Modulation of Tregs in Clinical Trials Presenter: Dr. Shimon Sakaguchi, MD, PhD; Date: September 22, 2023
    pptx file
    b clinical trial, in patients with solid tumors   6.00 MB   1 version
    Uploaded - 10-03-2023
    Meeting: 2023 Deep Dive in Cancer Immunotherapy Targets: Modulation of Tregs in Clinical Trials Presenter: Dr. Vaios Karanikas, PhD; Date: September 22, 2023

    Related Entries and Links

    No Related Resource entered.